A Novel Design of a Portable Birdcage via Meander Line Antenna (MLA) to Lower Beta Amyloid (Aβ) in Alzheimer’s Disease

📖 Top 20% JournalJul 14, 2025IEEE journal of translational engineering in health and medicine

A New Portable Device Using Meander Line Antenna to Reduce Beta Amyloid in Alzheimer's Disease

AI simplified

Abstract

A repeated electromagnetic field stimulation (REMFS) at 64 MHz with a (SAR) of 0.6 W/kg significantly reduced secreted amyloid-beta levels in primary human brain cultures.

  • Treatment with REMFS for one hour daily over 14 days led to a statistically significant decrease in amyloid-beta-42 and amyloid-beta-40 levels.
  • No evidence of toxicity was observed in the brain cultures following the REMFS treatment.
  • A portable RF device is being developed to deliver a SAR of 0.4-0.9 W/kg to memory areas of the human brain.
  • The device design includes a birdcage antenna to ensure uniform RF power distribution and to accommodate variations in patient anatomy.
  • The maximum temperature increase during exposure was less than 0.5°C, which is considered safe for clinical applications.
  • Future phases of the project will involve manufacturing the device and obtaining FDA approval for human trials.

AI simplified

Key numbers

46%
Reduction in Beta-Amyloid Levels
Observed in neuronal cultures subjected to REMFS at 64 MHz with a of 0.6 W/Kg.
0.4-0.9 W/kg
Range
Targeted levels for the proposed device to ensure safety and efficacy.

Key figures

FIGURE 1.
Typical MRI structure with components labeled in
Highlights the detailed design of a birdcage coil used to deliver uniform RF power in brain treatments
perez1-3559693
  • Panel single
    MRI birdcage coil with 16 (legs), 32 , two (-A and Port-B) positioned 90° apart, shield, port support, and end rings
FIGURE 2.
Structure and components of a portable with design
Highlights the detailed design of a flexible enabling uniform electromagnetic stimulation for Alzheimer's research.
perez2-3559693
  • Panel
    The birdcage coil includes 16 meander line coils ( or legs), 32 , and eight spaced at 45° intervals, with labeled parts such as shield, end rings, supports, and ports.
FIGURE 3.
Dimensions of a single segment in centimeters
Shows precise coil dimensions critical for designing a portable antenna to deliver targeted electromagnetic stimulation
perez3-3559693
  • Panel single
    A single coil segment of the birdcage based meander line antenna with labeled vertical and horizontal dimensions: 2.0 cm, 1.0 cm, 3.0 cm, 1.7 cm, 2.0 cm, and 4.4 cm
FIGURE 4.
Equivalent electrical circuit of the proposed birdcage based
Anchors the antenna design by showing the circuit elements that control RF power deposition and flexibility
perez4-3559693
  • Panel single
    Circuit components include labeled l_ER, l_R1, l_R2 and labeled C_top and C_bottom arranged to represent end-rings and of the antenna
FIGURE 5.
values at different tuning levels in a radio frequency device
Highlights how varying capacitor values adjust the S11 parameter, affecting device tuning at target frequencies
perez5-3559693
  • Panel
    S11 parameter (in dB) plotted against frequency (MHz) for multiple capacitor values ranging from 6.9 to 9.2 nF
1 / 5

Full Text

What this is

  • This research proposes a portable birdcage antenna design for treating Alzheimer's disease (AD) via repeated electromagnetic field stimulation (REMFS).
  • The device aims to lower toxic beta-amyloid levels in the brain, potentially improving memory function in AD patients.
  • The design focuses on delivering electromagnetic energy uniformly across brain regions while adhering to safety standards.

Essence

  • The portable birdcage antenna design targets the reduction of beta-amyloid levels in Alzheimer's disease through REMFS. It aims to provide effective treatment while ensuring safety and comfort for patients.

Key takeaways

  • The proposed device achieves a () of 0.4-0.9 W/kg, which is crucial for effective treatment without adverse effects.
  • REMFS at 64 MHz has demonstrated a 46% reduction in beta-amyloid levels in neuronal cultures, indicating potential efficacy in treating Alzheimer's disease.
  • The design allows for personalized adjustments to fit individual patient characteristics, enhancing treatment effectiveness and comfort.

Caveats

  • The transition from preclinical studies to human trials poses challenges in accurately translating RF power deposition and frequency settings.
  • Future studies must validate the device's effectiveness and safety in real-world clinical settings before widespread application.

Definitions

  • Specific Absorption Rate (SAR): The rate at which energy is absorbed per unit mass of tissue, crucial for assessing safety in RF exposure.

AI simplified